Wynn With This Just In
Clinical Articles Brought to You by Lexi-Comp
and Dr. Richard L. Wynn
Click here to subscribe to the Lexi-Comp Dentistry newsletter.
The purpose of this column is to keep professionals
informed of recent reports regarding drugs and other events which may
influence dental treatment. These reports will be gleaned from
scientific journals, screened for dissemination, and presented on a
timely basis and with great accuracy.
It is hoped the dental professional will reap
significant benefit from this information, and it will contribute to
superior patient care.
Each month a new article will be published. If you are
not on our mailing list but would like to receive these newsletters,
sign up now!
CURRENT
A New Report: Prevalence of Osteonecrosis of the Jaw in Patients Using Fosamax®-type Drugs is 0.1%
February 2010
PREVIOUS
Update on Aspirin Alerts
December 2009
Statin Users Taking CoQ10 Supplements
November 2009
Relationship Between C-reactive Protein & Periodontal Disease - Connecting Some of the Dots
October 2009
Prasugrel (Effient™), A Platelet Aggregation Inhibitor that is the New Kid on the Block Also: FDA Finalizes Device Ruling for Mercury and Dental Amalgam
September 2009
Update on Oral Bisphosphonate-Associated Osteonecrosis of the Jaw: New Informational Statement by the ADA; Oral Surgery Literature Reiterates Prevalence is Low
August 2009
Introducing a new drug monograph field, "Effects on Bleeding". Also, antidepressants are associated with increased bleeding.
July 2009
Premedication in Dental Patients with Joint Replacements
June 2009
Important Updates from the AAOS and ADA
May 2009
Aspirin and Heart Attacks
April 2009
Clopidogrel (Plavix®) as an Antiplatelet Agent - Genetics May Affect Drug Responsiveness
March 2009
The Safety of OraVerse™ - a Dental Drug that Speeds Up Return to Normal After Soft-tissue Anesthesia
February 2009
OraVerse™ - A Newly Approved Drug that is Effective in Children in Reversing Soft-tissue Local Anesthesia
January 2009
OraVerse™ - A Newly Approved Drug That Speeds Up Return to Normal After Soft-tissue Anesthesia
November 2008
Prevalence rate of necrotic jaw bone in patients taking Fosamax®-type drugs continues to be low. Plus, more on dental implant success in Fosamax patients.
October 2008
Endocarditis-Causing Bacteria Show Up in the Bloodstream After Toothbrushing
September 2008
Dental Amalgam, the FDA, and Two Safety Studies in Children
August 2008
Vitamin D - New Reports Boost Its Potential as an Anti-Inflammatory
July 2008
Alpha-Lipoic Acid Useful in Treating Burning Mouth Syndrome
June 2008
High Blood Pressure and Underactive Thyroid Gland (Hypothyroidism)
May 2008
Varenicline
(Chantix™) is effective in helping smokers quit, but it is
not without problems.
April 2008
Bisphosphonates
and Dental Implants
March 2008
A
Review of the Harvard Fosamax® Study
February 2008
Fosamax®
and Osteonecrosis of the Jaw – Some New and Frequently Asked
Questions
December 2007
The
Experts Weigh In On Osteonecrosis of the Jaw and Bisphosphonates: A New
Task Force Report
November 2007
New
American Heart Association Guidelines for Preventing Heart Disease in
Women
October 2007
Where
are we with the benefits of aspirin in women?
September 2007
Information
to the Patient from the ADA on the Issues of: (1) The change in
guidelines for antibiotic prophylaxis; (2) Oral bisphosphonates and
osteonecrosis of the jawbone; (3) The stent patient on aspirin and
Plavix®
August 2007
Additional
Treatment Options in the Management of Osteoporosis
July 2007
Osteonecrosis
of the Jaw in Cancer After Treatment with Bisphosphonates: More
Information from Australia
June 2007
New
Guidelines for the Prevention of Infective Endocarditis - the Bottom
Line
May 2007
More
on the Frequency of Oral Bisphosphonate-Associated Osteonecrosis of the
Jaw: A New Report from Australia
April 2007
Nonsteroidal
Anti-Inflammatory Drug Use in the First Trimester of Pregnancy
Increases the Risk of Congenital Anomalies
March 2007
Strong
Advisory Warning Against the Discontinuation of Dual
Aspirin/Clopidogrel (Plavix®) Antiplatelet Therapy in Patients
with Coronary Artery Stents
Feb. 2007
Articaine
(Septocaine®) Formulation with Less Vasoconstrictor Gains FDA
Approval
Jan. 2007
Ibuprofen
Dosing and Naproxen Use in Patients on Cardioprotective Aspirin
Nov 2006
Ibuprofen
Blunts Aspirin's Cardioprotection. FDA Issues Warning
Oct 2006
Johns
Hopkins and the Mayo Clinic Speak to the Issue of
Bisphosphonate-Associated Osteonecrotic Jaw Bone (ONJ)
Sep 2006
More
Findings on the Association Between Bisphosphonates and Osteonecrosis
of the Jaw
Aug 2006
Fosamax,
Boniva and Other Oral Bisphosphonates and Necrotic Jaw Bone
July 2006
Bisphosphonate-associated
osteonecrotic jawbone - continuing with more reports relative to dental
patient management
June 2006
Bisphosphonates,
including alendronate (Fosamax®), and ONJ
May 2006
|
